The fibrinolytic enzyme system is a potentially powerful biological mechanism that can be activated to digest fibrin, dissolve thrombi, and lyse fibrinous exudates. However, the relevance of the fibrinolytic enzyme system to the development of atheroma and thrombosis is uncertain in spite of circumstantial evidence to support an hypothesis that diminished fibrinolytic capacity is important in their pathogenesis (Astrup, 1959) . Despite the increase in clinical atheroma and thrombosis with advancing years, fibrinolytic activity has been found to remain either unaltered (Sawyer, Fletcher, Alkjaersig, and Sherry, 1960; Fearnley, Chakrabarti, and Avis, 1963; Nilsson, 1964; Moser and Hajjar, 1966) or even to increase with age (Hume, 1961; Swan, 1963) . We have examined age-dependent changes in fibrinogen and the major components of the fibrinolytic enzyme system by comparing a young, healthy population with a healthy, elderly group aged 66-96 years, living in the community.
Materials and Methods

SUBJECTS STUDIED
Ten male and 10 female healthy medical students, doctors, and technicians, aged (Ogston and Ogston, 1966) of the method described by Ratnoffand Menzie (1951).
Plasmaplasminogen Plasma plasminogen was assayed by the caseinolytic method of Remmert and Cohen (1949) as modified by Alkjaersig, Fletcher, and Sherry (1959 Fibrinogen-related antigen Fibrinogen-related antigen (FR-antigen) was assayed by the method of Merskey, Kleiner, and Johnson (1966) using the modifications described by Bonnar, Davidson, Pidgeon, McNicol, and Douglas (1969) . The assay was performed on serum stored at -70°C prepared from 5 ml of blood taken into plastic tubes containing 0 1 ml of a 1:20 dilution of Aprotinin, 100000 Kallikrein Inactivator Units per 10 ml (Trasylol, Bayer Pharmaceuticals Ltd, Haywards Heath, UK) and incubated for at least three hours at 37°C in a water bath before the serum was separated.
xti-Antitrypsin and x2-Macroglobulin These were assayed by quantitative single radial immunodiffusion of serum (Mancini, Carbonara, and Heremans, 1965) Age 30-2 + 5-1 71-1 ± 2-9 79 4 ± 3-2 89-7 ± 3-7 (years) (n = 20) (n=28) (n = 27) (n = 6) ESR 5-2 ± 2-8 10-5 ± 7-4 25-0 ± 19-1 17-7 ± 7-6 (mm/hour) Plasminogen activatoras measuredby theeuglobulin lysis time did not significantly differ in the 20-40 and 66-75-year-old subgroups: fibrinolytic activity in the over 75s was significantly higher than in the 20-40 (p < 0-05) and the 66-75 (p < 0-01) subgroups.
FR-antigen content of serum increased steadily (r = 0-51, p < 0-001) with age but the apparently steep increase in the over 86 compared to the 76-85-year-old subgroup did not attain statistical significance.
oci-Antitrypsin and ac2-macroglobulin both rose, significantly with age (r = 0-34, p < 0-01; r = 0-45, p < 0-001) although the actual increases were small and only the differences in mean levels of the 20-40 and 66-75-year-old groups attained statistical significance (p < 0-05, p < 0-025). The sex difference in levels of x2-macroglobulin described previously (Ganrot and Scherstdn, 1967) was not found in this study (r = 0-12).
THE INFLUENCE OF OBESITY
A narrow range of skinfold thickness was found with all subjects studied, the coefficient of variation over the triceps being only 13 % in males, 8 % in females.
There was a predictable correlation between sex and subcutaneous tissue thickness (r = 0-62, p < 0-001).
If males are considered alone a significant negative association between plasinogen activator and obesity was found(r = -0-31; p < 0-005). Thiswasnotfound in women. In agreement with a previous study (Warlow, McNeill, Ogston, and Douglas, 1972) obesity and fibrinogen levels were found to correlate significantly (r = 0-24, p < 0-01).
Discussion
Studies of physiological changes associated with aging pose special problems. The definition of normality is difficult and longevity itself may isolate an abnormal population with a particular physiological response to aging. Yet despite such inherent drawbacks to any study of physiological variations in the elderly, the present results do provide some insight into the effects of age upon haemostatic factors.
We have found no significant difference in fibrinolytic activity, as assessed by the euglobulin clot lysis time, between those aged 20 to 40 and those in the 66-75 years age group. This is in keeping with most previous studies concluding that fibrinolytic activity is unrelated to age (Sawyer et al, 1960; Fearnley et al, 1963; Nilsson, 1963; Moser and Hajjar, 1966) . The cause of the increased activity in subjects over the age of 75 is obscure. Exogenous factors such as anxiety, known to increase fibrinolytic activity (Ogston, McDonald, and Fullerton, 1962) , are likely to be of greater importance than any age-related augmentation of the response secondary to venous occlusion (Robertson, Pandolfi, and Nilsson, 1972) for the period of venous stasis involved in obtaining blood in this study was short.
The level of both ol-antitrypsin and M2-macroglobulin, the principal antiplasmins of blood, increased with age. The al-antitrypsin concentration is known to rise in acute and chronic inflammatory conditions, in neoplasia (Fagerhol and Laurell, 1970) , and after trauma; its rise in old age may reflect cellular damage. The significance and explanation of the increase in oc2-macroglobulin found with age is unknown: such an increase was not observed in a previous study of subjects under the age of 65 years (Ganrot and Schersten, 1967) .
The previously described rise in the plasma fibrinogen concentration with age (Ogston and Ogston, 1966) This study has demonstrated a progressive and considerable increase in the level of FR-antigen with age. The significance of such a rise is uncertain. It is possible that the increased levels in old age merely represent diffuse cellular damage (Wood, Prentice, and McNicol, 1972) . Alternatively, in association with the reduced plasminogen levels and lack of further increase in the fibrinogen level in the very elderly, the FR-antigen increase might be interpreted as evidence of mild disseminated intravascular coagulation. The latter explanation, however, fails to take account of increased levels of FR-antigen at ages when either plasminogen remained unchanged or fibrinogen concentrations are actually raised.
A number of studies have demonstrated an association between decreased plasma fibrinolytic activity and obesity (Goldrick, 1961; Ogston and McAndrew, 1964) . In the present study this association was found only in men: it seems probable that the narrow range of skinfold thickness used to assess the degree of obesity obscured the relationship in women.
It is clear that there are changes in the components of the fibrinolytic enzyme system in the elderly. How far these reflect occult tissue damage in old age or represent true physiological change must remain speculative, but they do demonstrate that any study of this system must take age into account.
